Kiniksa Pharmaceuticals International, plc (KNSA) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sanj K Patel

Chairman & CEO

—

$37.40M (15) scheduled

−$37.40M

1,969,594

2.5%

$185.63M

+69.8%

Ross Moat

Chief Operating Officer

—

$9.63M (11) scheduled

−$9.63M

10,294

0.013%

$970.21K

−52.6%

John F. Paolini

Chief Medical Officer

—

$8.94M (10) scheduled

−$8.94M

69,922

0.090%

$6.59M

+34.4%

Michael R Megna

Chief Accounting Officer

—

$3.42M (7) scheduled

−$3.42M

12,697

0.016%

$1.20M

−52.1%

Mark Ragosa

Chief Financial Officer

—

$3.39M (4) scheduled

−$3.39M

20,854

0.027%

$1.97M

−29.4%

Baker Bros. Advisors LP entity

Director

—

2,744,894

3.5%

$258.71M

+1.1%

Eben Tessari

Chief Strategy Officer

—

23,130

0.030%

$2.18M

−79.0%

Richard S Levy

Director

—

22,359

0.029%

$2.11M

+73.4%

Kimberly J Popovits

Director

—

15,345

0.020%

$1.45M

+63.7%

Tracey L McCain

Director

—

15,345

0.020%

$1.45M

+63.7%

Thomas Malley

Director

—

15,345

0.020%

$1.45M

+63.7%

Barry D Quart

Director

—

12,745

0.016%

$1.20M

+36.0%

G Bradley Cole

Director

—

7,172

0.009%

$675.96K

−23.5%

Kiniksa Pharmaceuticals International, plc

What the insiders did Scheduled selling only

By person